Brazilian Institute awards US$ 20,000 to a researcher for discovering an antibody that sets the path for the discovery of a treatment for Amyotrophic Lateral Sclerosis
Tuesday 7 December, 2021
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease which remains incurable. With the objective of calling attention to scientific studies that help to improve the quality of life of ALS patients and seek a cure for the disease, the Paulo Gontijo Institute (IPG) presents an annual award - the Paulo Gontijo Award- currently on its 13th edition. This year’s award was given to the Italian researcher Silvia Tozzi, whose research... Читать дальше...